TOP2A Overexpression as a Prognostic Biomarker in High-Grade Meningioma: An Integrated Single-Cell and Bulk Transcriptomic Study
- 1Department of Neurosurgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 17 Panjiayuan Nanli, Chaoyang District, Beijing 100021, China
Abstract
While prior single-cell studies have identified proliferative neoplastic subpopulations, the prognostic and therapeutic implications of TOP2A focal copy-number status have not been defined. This study aimed to delineate the cellular architecture of high-grade meningioma and to evaluate the clinical and prognostic significance of TOP2A expression together with its focal copy-number status through integrated single-cell and bulk transcriptomic profiling. Single-cell RNA sequencing (scRNA-seq) was integrated with bulk RNA sequencing (bulk RNA-seq) to resolve the cellular landscape of high-grade meningioma in an exploratory cohort, followed by functional subcluster identification, differential expression analysis, and survival analyses. TOP2A was prioritized for multi-level validation: mRNA overexpression was confirmed in an independent bulk cohort, protein overexpression by immunohistochemistry (IHC), and focal gene copy-number status by fluorescence in situ hybridization (FISH). Kaplan–Meier survival analysis was performed to evaluate patient prognosis. Correlations between continuous variables were assessed using Spearman’s rank correlation coefficient. scRNA-seq of an exploratory high-grade cohort revealed a cell-cycle proliferation cluster characterized by high TOP2A expression. In a 160-sample bulk RNA-seq cohort, TOP2A was overexpressed in high-grade and recurrent tumors, and elevated TOP2A mRNA was significantly associated with shorter progression-free survival (PFS). IHC on 154 specimens confirmed TOP2A protein overexpression, and FISH on 27 specimens demonstrated focal TOP2A copy-number gain enriched in high-grade cases. Copy-number gain was concordant with TOP2A mRNA levels. Although TOP2A mRNA and protein overexpression were each associated with shorter PFS, the limited size of the FISH subset precluded an independent survival analysis by copy-number status. This study identifies TOP2A mRNA and protein overexpression as a prognostic biomarker in high-grade meningioma, and shows that focal TOP2A copy-number gain is enriched in high-grade tumors and concordant with TOP2A expression. By integrating transcriptional overexpression with copy-number gain, our findings identify TOP2A as a candidate prognostic biomarker warranting prospective evaluation in high-grade meningioma.
Related
- Integrated Transcriptomic Analysis Identifies ENO3 as a Candidate Lactate Metabolism‐Associated Biomarker in Colorectal Cancer Metastasis
- Integrated transcriptomic and clinical analyses reveal the prognostic relevance of GPC3 and a putative ceRNA-associated relationship in gastric cancer
- Transcriptomic Profiling of Mouse Mammary Tumors Enables Prognostic and Predictive Biomarker Discovery for Human Breast Cancer
- Integrated Transcriptomic and Regulatory Network Analysis Reveals Distinct Molecular Subtypes with Prognostic Significance in Clear Cell Renal Cell Carcinoma
- Integrated single-cell and bulk transcriptomic profiling reveals coagulation-associated heterogeneity and prognostic SPINT2 in acute myeloid leukemia
BibTeX
@article{cai2026top2a,
title = {{TOP2A Overexpression as a Prognostic Biomarker in High-Grade Meningioma: An Integrated Single-Cell and Bulk Transcriptomic Study}},
author = {Hongqing Cai and Guanchao Xie and Houjie Liu and Yujia Chen and Huaixu Li and Jinghai Wan and Zekun Deng},
journal = {International Journal of Molecular Sciences},
year = {2026},
month = oct,
doi = {10.3390/ijms27208984},
url = {https://www.mdpi.com/1422-0067/27/20/8984},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - TOP2A Overexpression as a Prognostic Biomarker in High-Grade Meningioma: An Integrated Single-Cell and Bulk Transcriptomic Study
AU - Hongqing Cai
AU - Guanchao Xie
AU - Houjie Liu
AU - Yujia Chen
AU - Huaixu Li
AU - Jinghai Wan
AU - Zekun Deng
PY - 2026
DA - 2026/10/10
JO - International Journal of Molecular Sciences
DO - 10.3390/ijms27208984
UR - https://www.mdpi.com/1422-0067/27/20/8984
AB - While prior single-cell studies have identified proliferative neoplastic subpopulations, the prognostic and therapeutic implications of TOP2A focal copy-number status have not been defined. This study aimed to delineate the cellular architecture of high-grade meningioma and to evaluate the clinical and prognostic significance of TOP2A expression together with its focal copy-number status through integrated single-cell and bulk transcriptomic profiling. Single-cell RNA sequencing (scRNA-seq) was integrated with bulk RNA sequencing (bulk RNA-seq) to resolve the cellular landscape of high-grade meningioma in an exploratory cohort, followed by functional subcluster identification, differential expression analysis, and survival analyses. TOP2A was prioritized for multi-level validation: mRNA overexpression was confirmed in an independent bulk cohort, protein overexpression by immunohistochemistry (IHC), and focal gene copy-number status by fluorescence in situ hybridization (FISH). Kaplan–Meier survival analysis was performed to evaluate patient prognosis. Correlations between continuous variables were assessed using Spearman’s rank correlation coefficient. scRNA-seq of an exploratory high-grade cohort revealed a cell-cycle proliferation cluster characterized by high TOP2A expression. In a 160-sample bulk RNA-seq cohort, TOP2A was overexpressed in high-grade and recurrent tumors, and elevated TOP2A mRNA was significantly associated with shorter progression-free survival (PFS). IHC on 154 specimens confirmed TOP2A protein overexpression, and FISH on 27 specimens demonstrated focal TOP2A copy-number gain enriched in high-grade cases. Copy-number gain was concordant with TOP2A mRNA levels. Although TOP2A mRNA and protein overexpression were each associated with shorter PFS, the limited size of the FISH subset precluded an independent survival analysis by copy-number status. This study identifies TOP2A mRNA and protein overexpression as a prognostic biomarker in high-grade meningioma, and shows that focal TOP2A copy-number gain is enriched in high-grade tumors and concordant with TOP2A expression. By integrating transcriptional overexpression with copy-number gain, our findings identify TOP2A as a candidate prognostic biomarker warranting prospective evaluation in high-grade meningioma.
SN - 1422-0067
ER -